The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-γ and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertension

Sai Sindhu Thangaraj*, Christina Stolzenburg Oxlund, Micaella Pereira Da Fonseca, Per Svenningsen, Jane Stubbe, Yaseelan Palarasah, Daniel F J Ketelhuth, Ib Abildgaard Jacobsen, Boye L Jensen

*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

Fingerprint

Dive into the research topics of 'The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-γ and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertension'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science